Lieff Cabraser on Recovering Alpha with Non
Transcription
Lieff Cabraser on Recovering Alpha with Non
Non-Traditional Approaches To Antitrust and Securities Cases Presentation to Investment Company Institute May 2016 General Membership Meeting Bruce W. Leppla, M.S., JD. Partner Lieff Cabraser Heimann & Bernstein, LLP 415-956-1000 [email protected] 1164248.20 Non-Traditional Approaches To Antitrust and Securities Cases Creative Legal Work Can Lead To Substantial Recoveries For Investment Company Litigants (Case Studies) Game Plan: Ø Investment Losses due to fraud or serious corporate misconduct are inevitable. Ø When this happens, best practices includes a fiduciary duty to evaluate recovering assets entrusted to our care. Ø Investment loss recovery can be outsourced on a contingency fee basis at zero cost and for reasonable contingent attorneys’ fees. Ø My dual interest: Litigation Partner and Chairman of an Investment Firm. 2 Non-Traditional Approaches To Antitrust and Securities Cases Creative Legal Work Can Lead To Substantial Recoveries For Investment Company Litigants (Case Studies) Game Plan: Ø Brief Background in Anti-Trust Price-Fixing Ø A review of two very successful cases for institutional investors. Ø In re CDS Antitrust Litigation (SDNY). Ø Lieff Cabraser Securities and Antitrust Opt-Out Actions on behalf of Major Institutional Investors. Ø A discussion of what financial fraud negotiation/litigation can mean for you. Ø “The days of leaving money on the table are over.” General Counsel, University Endowment Fund. 3 Antitrust Price Fixing Claims: General Background Sherman Antitrust Act Section 1 Ø Prohibits unreasonable restraints of trade that injure competitors and/or consumers. Ø Examples include combinations or conspiracies to fix prices (it does not matter if the fixed price is a reasonable price, the fixing of prices is itself unreasonable); predatory pricing (selling goods or services below cost, causing competitors to suffer loss or exit the market); tying arrangements – an agreement by a vendor to sell a good or service but only on the condition that the buyer also purchases a different product (known as the “tied” product). Restraints can be horizontal or vertical. 4 Antitrust Price Fixing Claims: General Background Elements of a Sherman Act Section 1 Price Fixing Claim Ø There is an alleged combination or conspiracy between the defendants to fix the price of [insert the relevant good, commodity or service]. Ø Two tests: 1) Price Fixing is “Per Se” illegal; or 2) Price fixing is deemed illegal after applying the so-called “Rule of Reason” test. 1) Per Se Illegal: [Standard Favored by Plaintiffs.] US v. Socony-Vacuum Oil Co., 310 US 150 (1940): Any “combination formed for the purpose and with the effect of raising, depressing, fixing, pegging, or stabilizing the price of a commodity in interstate commerce is per se illegal.” Examples: Evidence of written price fixing agreement, or agreement to divide markets. Defenses: 1) No Agreement. 2) Price was not affected – so no damages. 2) Price Fixing is Deemed Illegal After Applying a Rule of Reason Test [Standard Favored by Defendants]. Core element of a Rule of Reason Price Fixing Claim: Ø The combination or conspiracy caused an unreasonable restraint of trade. Under Rule of Reason the Following Additional Elements Must be Proven: 5 Antitrust Price-Fixing Claims: General Background Elements of a Sherman Act Section 1 Price Fixing Claim (cont.) The alleged restraint had a substantial effect on interstate commerce and involved a substantial amount of such commerce. Ø To meet this test the plaintiff must define 1) the relevant goods or services market, 2) the geographic territory for such a market, and 3) that the defendants possessed sufficient market power to adversely effect competition in this market. Ø Market power, generally, includes the ability to control price, exclude competition, or restrict output. So we examine: 1) the nature of the industry, 2) facts specific, unique or peculiar to that industry, 3) the nature of the alleged restraint and its probable effect, 4) the history of the restraint, and 5) reasons for adopting the restraint – are they reasonable (e.g., a collaboration to develop a good or service, or unreasonable). Ø The plaintiff suffered injury in his business or property as the result of the alleged combination or conspiracy. Ø Under Both Theories: Ø Damages: if these elements are met, the court or jury may award damages. Treble damages are available in antitrust cases. Ø Note: the mere similarity or even identity of prices does not, without more, establish a conspiracy to fix prices. 6 In re CDS Antitrust Litigation Background Ø CDS (credit default swap): A type of financial derivative. Derivative: An instrument whose value is based on the value of an underlying asset or security. There are many types – e.g., derivatives based on loans, corporate debt instruments, equities, commodities, municipal guaranteed investment contracts, etc. etc. Ø A CDS derivative is a contract between the Seller (insurer) and buyer (insured) based whose value is based on the value of the underlying asset or security. The CDS buyer makes periodic premium payments. The CDS seller is required to make a lump sum payment to the buyer in the event, typically, of a credit default. A credit default can include ratings decline, loan payment default, bankruptcy, etc. 7 In re CDS Antitrust Litigation Background (cont.) In this case: Ø Plaintiffs: Investment Funds, both public funds and private investment firms, that purchased and/or sold CDS contracts during the Class Period. Ø Class Period: January 1, 2008 to September 25, 2015. Ø Principal Legal Claims: Ø First, CDS purchasers and sellers either paid more for a CDS contract, or received less on the sale of a CDS contract, than they would have but for the alleged conspiracy of defendants to “fix” the bid/ask spreads on CDS contract transactions. Ø How was this alleged market manipulation achieved? Primarily by: 1) denying entry to qualified market makers (e.g., Deutsche Borse, CME, Citadel Investments) to defendants’ CDS exchange; and 2) thereafter allegedly conspiring to fix the bid/ask spread in the purchase and sale of CDS’s in the US. 8 In re CDS Antitrust Litigation Background (cont.) Ø Defendants: Bank of America-Merrill Lynch, Barclays Capital, BNP Paribas, Citigroup, Credit Suisse, Deutsche Bank AG, Goldman Sachs & Co., HSBC Group, J.P. Morgan, Morgan Stanley, The Royal Bank of Scotland Group, Société Générale, UBS AG, and Wachovia Bank, N.A. (acquired by Wells Fargo) (“IB’s”). Ø Also Markit Group, owned by the IB’s, and the International Swaps and Derivatives Association (ISDA) based in NYC. Ø The Markit Group provides CDS transaction data. Ø The ISDA creates standardized derivatives contracts traded OTC. Ø Estimated Class-Wide Damages: Some estimates were up to $8 billion. Ø Status of the Class Case: Settled in October 2015 for $1,864,650,000, minus costs and attorney’s fees. Ø Damages Claim: Excessive bid-ask purchase price paid for CDS’s, and inadequate consideration received on sale. Again: Antitrust violations, if proved, carry treble damages remedies. 9 In re CDS Antitrust Litigation Notable Aspects of the CDS Antitrust Case First: Case Ideas can come from unlikely places. An inquiry into potential antitrust issues was first initiated by the US Department of Justice Antitrust Division. The US DOJ was interested in the fact that various investment banks (IB’s) owned the ICE, a derivatives clearing house. However, after an investigation of whether this ownership might have an adverse impact on competition, the DOJ dropped the inquiry. But, in April 2011 the EC opened a similar investigation. Ø Why did the EC open an investigation when the DOJ dropped its investigation? Ø Between 2006 and 2009, the Deutsche Borse and Chicago Mercantile Exchange (CME) tried to enter the CDS business. 2 issues were of interest to the EC: 1) Did IB’s and Markit collude to provide market information only to the IB’s. 2) Did IB’s and ICE collude to inhibit other clearing houses from entering the market? Ø The EC later opened its probe to include the ISDA. 10 In re CDS Antitrust Litigation Notable Aspects (cont.) Ø July 1, 2013: The EC issued a formal statement of objections to 13 IB’s (who controlled the ICE), Markit and ISDA that it had come to preliminary conclusion that the investment banks had violated EC antitrust rules and regulations prohibiting unlawful restraints of trade. Ø Shortly thereafter (in August and November 2013) the first US plaintiff class actions on behalf of US purchasers and sellers of CDS’s was filed in SDNY. Ø Lesson 1: Watch what the US and EC regulators investigate. Ø In the US private antitrust class actions two primary claims were made: 1) The 2008 Blocking of Entry into the CDS market of a proposed exchange, the CMDX, a JV between Citadel LLC and the CME. Denial of licenses for information supplied by Markit and to ISDA’s industry standard licensing agreements. (Even though Markit and ISDA would have enjoyed substantially higher profits from more market participants.) 2) Control Over CDS Clearing and Exclusion of Alternate Dealers from the ICE. The result: Excessive Bid/Ask spreads. 11 In re CDS Antitrust Litigation Notable Aspects (cont.) Second: Persistence. Once committed, the plaintiff litigant must go all in. Ø Note: The actions were filed in the US. But there were no pending US governmental alleged antitrust violation criminal charges. Nor were there any US government settlements, fines or penalties. Defendants’ Primary Claims Ø Conspiracy allegations were implausible and unproven. Ø Alleged injuries to class members were too remote to provide the basis of an antitrust claim. Ø The statute of limitations barred the bulk of the claims. Ø Dodd-Frank preempted the application of the antitrust laws to the case. Plaintiffs’ Burden to Rebut these Claims Ø The case required substantial litigation funding demands with no guarantee of any return: E.g., 3 years of lodestar for countless attorneys; over 3 million pages of document review; 27 adverse fact depositions; 24 depositions of third parties; briefing on 4 motions to dismiss which required detailed factual inquiry to tease out facts that show alleged collusion and conspiracy; and all the while over 15 of the largest defense law firms globally fighting the case. 12 In re CDS Antitrust Litigation Notable Aspects (cont.) Third: Novel Theory of Proof of damages. Ø Notional value of the CDS transactions was in the trillions. Ø Multi-step process to determine class damages: 1) Theory: Effectively barring CDMX from the market led to lack of a) competition with respect to bid-ask spread and b) led to lack of transparency of bid-ask spread; 2) The bid-ask spread was therefore wider than in other forms of exchange transactions where the bid–ask spread can be calculated over time; and 3) In an effort to prove all of this the plaintiffs had to persuade the court to compel defendants to produce transaction data. 4) Then, the plaintiffs had to analyze data points for millions of transactions, removing non-qualifying transactions. Plaintiffs retained former CDS traders to testify as to the manner in which transaction quotes were given to the market; and econometricians and statisticians to create algorithms down to hours in the trading day going back 5 years. All of this was then compared to bid-ask spreads that are common in the US corporate bond market. Ø Expert work alone required a millions of $$$ of academic and econometric damages analysis. 13 In re CDS Antitrust Litigation Notable Aspects (cont.) Fourth: Timing. The global CDS antitrust case settled in October 2015. Ø But: On December 4, 2015, the European Commission, whose inquiry in July 2013 had initiated the entire case, decided to close its investigation: Ø “The Commission has decided to close antitrust proceedings against all 13 investment banks involved in the investigation into the credit default swap market… Today’s closure regarding the 13 investment banks is based on a thorough analysis of all information received from the parties in their replies and during an oral hearing in May 2014, as well as on documents obtained through additional fact finding. The evidence was not sufficiently conclusive to confirm the Commission’s concerns with regard to the 13 investment banks.” So – Great timing! Fifth: All along, the plaintiff investment funds supported the case, and they and the class obtained substantial financial benefit as a result. 14 Introducing Lieff Cabraser Ø One of the Nation's Largest Plaintiffs' Law Firms Ø 40+ years of experience Ø 80+ lawyers in San Francisco, New York, Nashville & Seattle Ø Lead or Co-Lead Counsel in 300+ Class Actions Nationwide Ø Recoveries Exceed $97 Billion in 7 Practice Areas including Antitrust and Securities & Financial Fraud Ø 25 Trial Verdicts and Settlements totaling over $1 Billion Ø Recognitions: The National Law Journal’s “Elite Trial Lawyers: The 50 Leading Plaintiff Firms in America,” “Plaintiffs’ Hot List;” U.S. News and Best Lawyers’ “Law Firm of the Year” and Law360’s “Most Feared Plaintiffs’ Firms” 15 Lieff Cabraser’s Antitrust and Securities Fraud Negotiation and Litigation Services Case Evaluation, Analysis, and Loss Calculations Monitor U.S. and foreign securities litigation matters Comprehensive analysis and written case evaluations Economic loss and recoverable damages assessments (FIFO and LIFO) Ø Selective approach to recommending cases Ø Litigation options include: Seeking Lead Plaintiff status in class litigation, Opt-Out/Direct Action or Pre-Filing Demand Ø Network of sophisticated foreign law firms Ø Ø Ø Ø 16 Lieff Cabraser’s Opt-Out Litigation Practice Ø Lead plaintiff in class action represents the entire class of aggrieved investors, except those investors who “opt-out” of the class. Ø Some “opt-out” of the class, hire their own lawyers, and negotiate / litigate investment loss recovery on their own. Ø Fiduciarydutytoconsideralternativemethodstorecover largelosses Ø Potentialforsubstantiallygreaterfinancialrecoveries 17 Lieff Cabraser’s Opt-Out Litigation Practice Ø Opportunity to choose legal counsel and negotiate fee arrangements separately Ø Opportunity for pre-litigation negotiation / resolution of claim Ø Institutional investor’s threat of trial is credible, raising the value of its case Ø Control over litigation strategy, settlement, trial, and appeal Ø Potential to assert significant additional claims for relief (state law claims, etc.) Ø Potential to seek punitive damages and other remedies not generally available to the class plaintiff Ø Upon resolution, immediate receipt of settlement funds 18 Opt-Out Litigation Case Study: Qwest 19 Representative Securities Litigation Opt-Out Recoveries 20 Lieff Cabraser’s Judicial Recognition Ø “This really was an extraordinary case in which plaintiff’s counsel performed…an extraordinary service... They did a wonderful job in this case. . . . This was an outrageous wrong committed … and plaintiffs’ counsel deserve a world of credit for taking it on, for running the risk, for financing it and doing a great job.” § U.S. District Court Judge Lewis A. Kaplan § Southern District of New York Ø “Notably, Attorney Richard Heimann’s trial performance ranks as one of the best this judge has seen in sixteen years on the bench.” § 21 U.S. District Court Judge William Alsup § Northern District of California Representative Lieff Cabraser Clients 22 PrivateInstitutionalClients PublicFundClients BlackRock NewYorkStateCommon Retirement Fund LordAbbett NYCPensionFunds CharlesSchwab NJOfficeoftheTreasury JanusCapitalCorp. StateRetirementSystemsofPA,ME, Ohio,Iowa,MD,MI,others Dodge &Cox CalSTRS NuveenInvestments LA,Dallas,Houston andother municipal retirementsystems FranklinTempleton UCRegentsEndowmentFund Hermes Numerous LaborUnionFunds Non-Traditional Approaches To Antitrust and Securities Cases My partners and I would be pleased to discuss your firm’s opportunities for investment loss recovery. Legal creativity can lead to significant Institutional Investor recoveries. Pleasecallorwrite: BruceW.Leppla,Partner LieffCabraserHeimann&BernsteinLLP [email protected] 415-956-1000x3381 415-309-3535 23